Kisspeptin-54
Kisspeptin-54 (Metastin)
The full-length human kisspeptin with longer half-life than Kisspeptin-10. Used in clinical trials for reproductive medicine.
Typical Cost
Clinical setting only
Status
Research
Peptide Profile
Kisspeptin-54
Mechanism of Action
Same mechanism as Kisspeptin-10 but with longer duration of action. Activates kisspeptin receptors to stimulate GnRH and downstream reproductive hormones.
Common Dosages
intravenous
Clinical setting only
Varies by protocol · Varies
Benefits
Longer half-life than KP-10
Clinical trial data
Fertility restoration
Predictable response
Side Effects
Requires IV administration
Medical supervision needed
Limited availability
Key Research
Kisspeptin-54 fertility trials
Successful oocyte maturation in IVF protocols
Regulatory Status
In clinical trials. Not FDA-approved. Used in research settings for fertility treatments.
Contraindications
- ⚠Requires medical supervision
Not available for general use. For fertility, consult reproductive endocrinologist.
Learn More →Find peptide providers
Search 18,000+ clinics offering peptide therapy alongside GLP-1 medications.
Search Providers →Disclaimer: This information is for educational and research purposes only. Peptides described here may not be FDA-approved for human use. Always consult a qualified healthcare provider before using any peptide product. GLP1Search does not sell peptides.